Cavitary Lung Lesion Diagnosis and Management

Imaging Evaluation

The European Respiratory Society recommends that chest CT without IV contrast is used to evaluate a cavitary lung lesion, with thin sections (1.5 mm) to properly characterize the lesion 3
CT helps characterize the lesion and shows associated hilar or mediastinal lymphadenopathy or evidence of other abnormalities suitable for biopsy, as suggested by the Thorax journal 1
The presence of a fungal ball/aspergilloma within the cavity can be identified on CT, according to the European Respiratory Journal 4, 5
Multiple vs. solitary lesions can be distinguished on CT, with implications for diagnosis and management, as noted in the Thorax journal 1, 4
Associated pleural thickening or effusion can be identified on CT, which may inform the diagnosis and management plan, as reported in the European Respiratory Journal 5

The American Thoracic Society recommends complete blood count with differential to assess for evidence of infection, inflammation, or malignancy, although the specific recommendation is from Praxis Medical Insights 3
Inflammatory markers (C-reactive protein, erythrocyte sedimentation rate) can be used to assess for infection or inflammation, as suggested by Praxis Medical Insights 3
Blood cultures can be used to identify potential infectious causes, according to Praxis Medical Insights 3
Specific serological tests, such as Aspergillus IgG antibody test and galactomannan antigen, can be used if fungal infection is suspected, as recommended by the European Respiratory Journal 6, 5

The Infectious Diseases Society of America recommends bronchoscopy with bronchoalveolar lavage (BAL) as the first invasive diagnostic procedure, as reported in Clinical Infectious Diseases 7
BAL samples should be sent for cytologic assessment, Gram staining and fungal staining, bacterial, fungal, and mycobacterial cultures, and galactomannan testing, as suggested by Clinical Infectious Diseases 7
CT-guided percutaneous transthoracic needle biopsy (PTNB) should be considered if bronchoscopy is negative or not feasible, or if a tissue diagnosis is needed to guide management, as recommended by the Thorax journal 1, 2

Malignancy (primary lung cancer or metastases) is a common cause of cavitary lung lesions in adults, particularly with thicker cavity walls, older age, smoking history, and hemoptysis, as noted in the Thorax journal 2
Fungal infections (Aspergillus species) can cause cavitary lung lesions, typically presenting as aspergillomas or chronic cavitary pulmonary aspergillosis, according to the European Respiratory Journal 6, 5
Rheumatoid nodules and other autoimmune conditions, such as granulomatous diseases like Wegener's granulomatosis, can cause cavitary lung lesions, as reported in the Thorax journal 4

Cavitating lesions are usually caused by tumors or abscesses, and the clinical picture often helps distinguish between these diagnoses, as noted in the Thorax journal 1
Patients with lesions requiring diagnosis should be discussed in a multidisciplinary meeting with a respiratory physician and radiologist at minimum, as recommended by the Thorax journal 1, 2
For peripheral lesions abutting the pleura, ultrasound-guided biopsy can be considered to minimize pneumothorax risk, as suggested by the Thorax journal 1